Making Science Announces Sale of its Cloud and Cybersecurity Unit to Lutech
8.10.2025 10:24:00 CEST | Business Wire | Press Release
Making Science Group, S.A. (BME Growth: MAKS) (“Making Science”), a leading digital marketing and technology consulting firm, and Lutech S.p.A. (“Lutech”), a digital leader headquartered in Italy, announced today that they have entered into an agreement pursuant to which Making Science will sell its Cloud and Cybersecurity business unit in Spain to Lutech.
The transaction enables Making Science to concentrate its resources on consolidating its leadership in its core digital marketing, AdTech, and artificial intelligence segments.
For Lutech, the acquisition represents a new strategic expansion of its presence in the Spanish market and an enhancement of its service portfolio with a team of highly specialized professionals.
TRANSACTION OVERVIEW AND RATIONALE
The transaction will be effected by the sale and purchase of Making Science’s legal entities in Spain that operate in the cloud infrastructure, enterprise software development, and cybersecurity services segments.
The consideration payable under the transaction is a maximum of €26 million and consists of an upfront payment plus an additional payment to be paid in the first half of 2026, based on actual 2025 EBITDA.
Closing of the transaction, expected in Q4 2025, is subject to foreign direct investment approval in Spain and the fulfillment of customary conditions precedent for this type of transaction.
For Making Science, the divestment allows the company to focus its resources and management capabilities on its core business units: Digital Marketing Services, AdTech, and RAISING (its Artificial Intelligence technology division). These are the segments where the company has developed distinct competitive advantages and holds the greatest opportunities to become a global leader in both categories, maximizing international expansion and value creation.
For Lutech, this acquisition is another significant step in its international growth strategy. It establishes a strong foothold in the Spanish market, incorporating a talented team with a proven track record and a solid client base which further strengthens the presence of Lutech in Spain with Lutech Sapimsa and Cimworks. The addition of this unit strengthens Lutech's capabilities in high-demand areas such as cloud services, custom software, and cybersecurity, enhancing its offering for clients across Europe.
Lutech was advised by PCB Partners, DLA Piper and EY. Making Science was advised by GP Bullhound and Gómez-Acebo & Pombo.
A CONTINUED PARTNERSHIP
The transaction is structured to ensure complete operational continuity for all current clients and the seamless integration of the expert team into Lutech. Furthermore, Making Science and Lutech confirmed a strategic alliance whereby Making Science will continue to be an important customer of this business unit, ensuring that its clients maintain seamless access to the differentiated skillset and technology of its former cloud and cybersecurity unit.
Lutech is a leading Italian technology group in the development and implementation of enterprise solutions, with a proven track record in the management and development of high-performance technical teams. Its profile guarantees not only continuity in service to current customers, but also optimal conditions for the future growth of the acquired team.
José Antonio Martínez, CEO and Founder of Making Science, said:
"This transaction represents a strategic milestone in Making Science's evolution toward a more specialized and efficient organization. We are delighted to have found an ideal partner in Lutech, a top-tier group that guarantees the best possible future for the team and continuity of service for its clients. This agreement allows us to focus our resources on our global digital marketing and AI businesses, where we have the ability to establish sustainable leadership positions, while forging a new strategic relationship with Lutech."
Giuseppe Di Franco, CEO of Lutech Group, said:
"This acquisition is a key step in our international expansion strategy and reinforces our leadership in digital transformation services across Europe. We are impressed by the talent and expertise of the team at Making Science's Cloud, Software, and Cybersecurity unit, and we are excited to welcome them to the Lutech family. Together, we will enhance our ability to serve our clients in Spain and across Europe, and we are committed to ensuring a seamless transition for clients and investing in the team's future growth."
FINANCIAL IMPACT AND GUIDANCE
Making Science will provide more information on the planned use of the capital obtained once the transaction has been completed. In its H1 Results release dated July 31, 2025, Making Science reaffirmed its financial guidance for the fiscal year 2025. Making Science will communicate any updates to its 2025 Guidance or its 2027 Plan to the market after the transaction is completed.
ABOUT MAKING SCIENCE
Making Science is an AI-powered digital acceleration company that currently has more than 1,200 employees and a presence and technological development in 18 markets: Spain, Portugal, Mexico, Argentina, Colombia, Brazil, France, Netherlands, Italy, UK, Ireland, Sweden, Denmark, Norway, Finland, Germany, Georgia and USA. As a consulting partner of Local Planet, the world’s largest network of independent media agencies, Making Science offers digital marketing, Adtech and Martech, cloud technologies and software, and cybersecurity services globally, through delivery hubs that drive job creation and the availability of highly skilled technology talent.
Making Science is comprised of 4 business lines: the Global Digital Agency with Technology, with 360 digital advertising services that integrate strategic planning, creativity, data and technology; RAISING, the Technology Division, which combines business expertise with data science to offer advanced solutions based on AI applied to marketing; the Cloud, Software and Cybersecurity business, with a team of more than 400 engineers and data scientists for the development of cloud-based solutions and a specialised cybersecurity team; and the Making Science Investment area, with Ventis and TMQ, as a line of business diversification and implementation of the capabilities of all areas of Making Science.
RAISING, the technology division, positions the company as a global leader in digital transformation. Its proprietary solutions - ad-machina, Trust Generative AI and Gauss AI - enable brands to maximise their business results propelled by Artificial Intelligence.
In addition, the company participates in various ESG initiatives, including the Climate Pledge, the United Nations Global Compact, and the Pledge 1% initiative, supporting non-profit organisations in its community with a strong commitment to positively impacting the future.
ABOUT LUTECH
Lutech Group, a leader in Italy and a European player in digital and AI, designs, implements, and manages solutions for digital transformation, innovation, and the growth of companies and institutions, thanks to its in-depth knowledge of industry-specific processes.
With 5,500 professionals and revenues of around €1 billion, Lutech Group drives change through an end-to-end journey in which business consulting, execution, and governance maximize business results, delivering a complete and integrated offering.
Lutech expands and updates its portfolio of solutions and services through strategic acquisitions and continuous investments in people, platforms, and geographic areas.
For more information, visit www.lutech.group
View source version on businesswire.com: https://www.businesswire.com/news/home/20251007971676/en/
Contacts
Linda Cureton
makingscience@teamgingermay.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press Release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom